230 related articles for article (PubMed ID: 12663688)
1. Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity.
Potschka H; Fedrowitz M; Löscher W
J Pharmacol Exp Ther; 2003 Jul; 306(1):124-31. PubMed ID: 12663688
[TBL] [Abstract][Full Text] [Related]
2. Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.
Potschka H; Fedrowitz M; Löscher W
Epilepsia; 2003 Dec; 44(12):1479-86. PubMed ID: 14636316
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats.
Hoffmann K; Löscher W
Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain.
Potschka H; Löscher W
Neuroreport; 2001 Aug; 12(11):2387-9. PubMed ID: 11496115
[TBL] [Abstract][Full Text] [Related]
5. Expression of the multidrug transporter MRP2 in the blood-brain barrier after pilocarpine-induced seizures in rats.
Hoffmann K; Gastens AM; Volk HA; Löscher W
Epilepsy Res; 2006 Apr; 69(1):1-14. PubMed ID: 16504477
[TBL] [Abstract][Full Text] [Related]
6. Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats.
van Vliet EA; Redeker S; Aronica E; Edelbroek PM; Gorter JA
Epilepsia; 2005 Oct; 46(10):1569-80. PubMed ID: 16190927
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy.
Luna-Tortós C; Fedrowitz M; Löscher W
Neuropharmacology; 2010 Jun; 58(7):1019-32. PubMed ID: 20080116
[TBL] [Abstract][Full Text] [Related]
8. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
Baltes S; Gastens AM; Fedrowitz M; Potschka H; Kaever V; Löscher W
Neuropharmacology; 2007 Feb; 52(2):333-46. PubMed ID: 17045309
[TBL] [Abstract][Full Text] [Related]
9. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.
Smeets PH; van Aubel RA; Wouterse AC; van den Heuvel JJ; Russel FG
J Am Soc Nephrol; 2004 Nov; 15(11):2828-35. PubMed ID: 15504935
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of multidrug resistance-associated protein 2 in the brain of pentylenetetrazole-kindled rats.
Yao D; Liu L; Jin S; Li J; Liu XD
Neuroscience; 2012 Dec; 227():283-92. PubMed ID: 23059797
[TBL] [Abstract][Full Text] [Related]
11. Hyperammonemia enhances the function and expression of P-glycoprotein and Mrp2 at the blood-brain barrier through NF-κB.
Zhang J; Zhang M; Sun B; Li Y; Xu P; Liu C; Liu L; Liu X
J Neurochem; 2014 Dec; 131(6):791-802. PubMed ID: 25200138
[TBL] [Abstract][Full Text] [Related]
12. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis.
Kubota H; Ishihara H; Langmann T; Schmitz G; Stieger B; Wieser HG; Yonekawa Y; Frei K
Epilepsy Res; 2006 Mar; 68(3):213-28. PubMed ID: 16361082
[TBL] [Abstract][Full Text] [Related]
13. In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats.
Potschka H; Löscher W
Epilepsia; 2001 Oct; 42(10):1231-40. PubMed ID: 11737157
[TBL] [Abstract][Full Text] [Related]
14. Quantitative in vivo microdialysis study on the influence of multidrug transporters on the blood-brain barrier passage of oxcarbazepine: concomitant use of hippocampal monoamines as pharmacodynamic markers for the anticonvulsant activity.
Clinckers R; Smolders I; Meurs A; Ebinger G; Michotte Y
J Pharmacol Exp Ther; 2005 Aug; 314(2):725-31. PubMed ID: 15860570
[TBL] [Abstract][Full Text] [Related]
15. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
[TBL] [Abstract][Full Text] [Related]
16. The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy.
Brandt C; Bethmann K; Gastens AM; Löscher W
Neurobiol Dis; 2006 Oct; 24(1):202-11. PubMed ID: 16928449
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain.
Potschka H; Fedrowitz M; Löscher W
Neuroreport; 2001 Nov; 12(16):3557-60. PubMed ID: 11733711
[TBL] [Abstract][Full Text] [Related]
18. Impact of seizure activity on free extracellular phenytoin concentrations in amygdala-kindled rats.
Potschka H; Baltes S; Fedrowitz M; Löscher W
Neuropharmacology; 2011; 61(5-6):909-17. PubMed ID: 21736886
[TBL] [Abstract][Full Text] [Related]
19. MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid.
Huisman MT; Chhatta AA; van Tellingen O; Beijnen JH; Schinkel AH
Int J Cancer; 2005 Sep; 116(5):824-9. PubMed ID: 15849751
[TBL] [Abstract][Full Text] [Related]
20. Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2).
Lalloo AK; Luo FR; Guo A; Paranjpe PV; Lee SH; Vyas V; Rubin E; Sinko PJ
BMC Med; 2004 May; 2():16. PubMed ID: 15125776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
